tirzepatide tablets effectiveness Pills vs. Injections for Weight Loss the dual Oral Tirzepatide: What the Research

Generally, GLP-1 agonist medications are FDA approved for adults aged 18 years and older with certain body mass indexes (BMI) (typically a BMI of 30 or above, or a BMI of 27 or above if you have a weight-related health condition such as hypertension, high cholesterol, weight-related anxiety, liver disease, sleep apnea or PCOS)

Physiol Rep 3(11):e12610 Acosta A, Camilleri M, Shin A, Vazquez-Roque MI, Iturrino J, Burton D et al (2015b) Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy

MT and ZNG1 are also included in Fig

Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade

[ Links ] 13

If that sounds familiar, your injection timing might be working against your own biology